Authors: PARIDAENS R ROY JA NOOIJ M KLIJN J HOUSTON SJ BEEX LVAM VINHOLES J TOMIAK E VANVRECKEM A LANGENAEKEN C VANGLABBEKE M PICCART MJ

Citation: R. Paridaens et al., VOROZOLE (RIVIZOR(TM)) - AN ACTIVE AND WELL TOLERATED NEW AROMATASE INHIBITOR FOR THE TREATMENT OF ADVANCED BREAST-CANCER PATIENTS WITH PRIOR TAMOXIFEN EXPOSURE, Anti-cancer drugs, 9(1), 1998, pp. 29-35

Authors: BOCCARDO F AMOROSO D IACOBELLI S IRTELLI L FARRIS A MUSTACCHI G MESITI M BREMA F PACINI P CORTESI E NARDINI P GUIDA G LANGENAEKEN C

Citation: F. Boccardo et al., CLINICAL EFFICACY AND ENDOCRINE ACTIVITY OF VOROZOLE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC PHASE-II STUDY, Annals of oncology, 8(8), 1997, pp. 745-750